IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26FDA’s decision follows ...
Early-phase clinical trials are undergoing a quiet but consequential transformation. Once considered a relatively narrow checkpoint focused on basic safety and tolerability, these early-phase studies ...
Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...
Asianet Newsable on MSN
NeOnc Technologies receives UAE IND approval for NEO100, expanding global development ahead of anticipated phase 2 data milestone
Authorization covers all three NEO100 programs across adult Phase 1 through Phase 2, plus pediatric studies< Extends NeOnc’s ...
This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...
LONDON--(BUSINESS WIRE)--The increasing competition of the pharmaceutical industry has encouraged companies to invest in innovation and drug development. However, the drug development process is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results